Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 3
2005 3
2006 6
2007 5
2008 2
2009 1
2010 3
2011 2
2012 1
2014 1
2016 1
2017 1
2018 2
2019 4
2020 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
The role of cancer nurses in cancer-related pain management in Europe.
de Munter J, Dodlek N, Khmaladze A, Parreira ST, Ullgren H, de Man R, de Jong FA, Oldenmenger WH. de Munter J, et al. Among authors: de jong fa. Palliat Care Soc Pract. 2023 Dec 14;17:26323524231216996. doi: 10.1177/26323524231216996. eCollection 2023. Palliat Care Soc Pract. 2023. PMID: 38106339 Free PMC article. Review.
Management of fatigue in patients with cancer -- a practical overview.
Koornstra RH, Peters M, Donofrio S, van den Borne B, de Jong FA. Koornstra RH, et al. Among authors: de jong fa. Cancer Treat Rev. 2014 Jul;40(6):791-9. doi: 10.1016/j.ctrv.2014.01.004. Epub 2014 Feb 7. Cancer Treat Rev. 2014. PMID: 24576643 Review.
Role of pharmacogenetics in irinotecan therapy.
de Jong FA, de Jonge MJ, Verweij J, Mathijssen RH. de Jong FA, et al. Cancer Lett. 2006 Mar 8;234(1):90-106. doi: 10.1016/j.canlet.2005.04.040. Epub 2005 Dec 15. Cancer Lett. 2006. PMID: 16343744 Review.
Medicinal cannabis in oncology.
Engels FK, de Jong FA, Mathijssen RH, Erkens JA, Herings RM, Verweij J. Engels FK, et al. Among authors: de jong fa. Eur J Cancer. 2007 Dec;43(18):2638-44. doi: 10.1016/j.ejca.2007.09.010. Epub 2007 Oct 31. Eur J Cancer. 2007. PMID: 17976975 Review.
A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan.
van der Bol JM, Mathijssen RH, Creemers GJ, Planting AS, Loos WJ, Wiemer EA, Friberg LE, Verweij J, Sparreboom A, de Jong FA. van der Bol JM, et al. Among authors: de jong fa. Clin Cancer Res. 2010 Jan 15;16(2):736-42. doi: 10.1158/1078-0432.CCR-09-1526. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068078 Clinical Trial.
Post-gemcitabine therapy for patients with advanced pancreatic cancer - A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens.
Vogel A, Ciardiello F, Hubner RA, Blanc JF, Carrato A, Yang Y, Patel DA, Ektare V, de Jong FA, Gill S. Vogel A, et al. Among authors: de jong fa. Cancer Treat Rev. 2016 Nov;50:142-147. doi: 10.1016/j.ctrv.2016.09.001. Epub 2016 Sep 9. Cancer Treat Rev. 2016. PMID: 27676174 Review.
Effects of methimazole on the elimination of irinotecan.
van der Bol JM, Visser TJ, Loos WJ, de Jong FA, Wiemer EA, van Aken MO, Planting AS, Schellens JH, Verweij J, Mathijssen RH. van der Bol JM, et al. Among authors: de jong fa. Cancer Chemother Pharmacol. 2011 Jan;67(1):231-6. doi: 10.1007/s00280-010-1414-x. Epub 2010 Aug 1. Cancer Chemother Pharmacol. 2011. PMID: 20680278 Free PMC article.
37 results